Bamco Inc. NY acquired a new stake in Agilent Technologies, Inc. (NYSE:A - Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The fund acquired 36,589 shares of the medical research company's stock, valued at approximately $4,860,000.
Several other institutional investors have also added to or reduced their stakes in the business. SHP Wealth Management purchased a new stake in shares of Agilent Technologies in the fourth quarter worth about $26,000. Core Wealth Advisors LLC purchased a new position in shares of Agilent Technologies in the 4th quarter worth about $26,000. Navalign LLC purchased a new stake in Agilent Technologies in the fourth quarter worth approximately $27,000. MV Capital Management Inc. purchased a new stake in shares of Agilent Technologies in the 4th quarter valued at $28,000. Finally, Entrust Financial LLC bought a new position in shares of Agilent Technologies during the 4th quarter valued at $31,000.
Agilent Technologies Price Performance
Shares of NYSE A opened at $157.60 on Friday. The company has a 50 day simple moving average of $139.76 and a two-hundred day simple moving average of $126.85. The company has a market capitalization of $44.51 billion, a price-to-earnings ratio of 31.02, a P/E/G ratio of 2.74 and a beta of 1.25. Agilent Technologies, Inc. has a fifty-two week low of $108.35 and a fifty-two week high of $163.75. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10.
Agilent Technologies (NYSE:A - Get Free Report) last released its earnings results on Wednesday, August 26th. The medical research company reported $1.62 EPS for the quarter, topping analysts' consensus estimates of $1.49 by $0.13. The firm had revenue of $1.88 billion for the quarter, compared to analysts' expectations of $1.84 billion. Agilent Technologies had a return on equity of 24.84% and a net margin of 19.53%.The company's quarterly revenue was up 8.1% on a year-over-year basis. During the same period in the prior year, the firm posted $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Analysts expect that Agilent Technologies, Inc. will post 6.05 EPS for the current fiscal year.
Analyst Ratings Changes
Several analysts have weighed in on A shares. Weiss Ratings raised shares of Agilent Technologies from a "hold (c-)" rating to a "hold (c)" rating in a research note on Tuesday, June 2nd. Sanford C. Bernstein raised their price objective on Agilent Technologies from $155.00 to $180.00 and gave the company an "outperform" rating in a research note on Thursday. Wall Street Zen upgraded Agilent Technologies from a "hold" rating to a "buy" rating in a report on Sunday, August 2nd. Barclays boosted their target price on Agilent Technologies from $150.00 to $175.00 and gave the company an "overweight" rating in a research note on Thursday. Finally, Citigroup increased their target price on Agilent Technologies from $185.00 to $190.00 and gave the company a "buy" rating in a report on Thursday. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $170.33.
Check Out Our Latest Report on A
Agilent Technologies News Summary
Here are the key news stories impacting Agilent Technologies this week:
- Positive Sentiment: Agilent reported fiscal Q3 revenue of $1.88 billion, up 8.1% year over year and ahead of the $1.84 billion consensus estimate. Adjusted EPS was $1.62, beating expectations of approximately $1.49 and rising from $1.37 a year earlier. Operating profit, cash flow and margins also improved. Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results
- Positive Sentiment: The company raised its fiscal 2026 outlook to adjusted EPS of $6.18-$6.21, above the $6.06 analyst consensus, and projected approximately $7.5 billion in revenue versus expectations of $7.4 billion. Management cited improving demand for laboratory instruments used in research and drug development. Agilent raises annual profit forecast on improving lab tools demand
- Positive Sentiment: Analyst sentiment strengthened significantly following the results. Citigroup and JPMorgan raised their price targets to $190, while RBC lifted its target to $185. Barclays, Stifel, Goldman Sachs, Bank of America, TD Cowen and Bernstein also raised targets, with most assigning Buy, Overweight or Outperform ratings. The revised targets imply roughly 11%-21% potential upside from the referenced trading level. Analyst price-target revisions
- Neutral Sentiment: Agilent is trading near its 52-week high and above both its 50-day and 200-day moving averages. That momentum supports investor confidence, although the stock’s valuation—around 32 times earnings and a PEG ratio above 2.7—leaves less room for disappointment.
- Neutral Sentiment: Institutional positioning was mixed in the latest filings: 594 investors added shares while 550 reduced holdings. Significant purchases by FMR, JPMorgan, Bank of New York Mellon and T. Rowe Price were offset by large sales from several other institutions.
About Agilent Technologies
(
Free Report)
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Featured Articles
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Agilent Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.
While Agilent Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
